tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market
Advertisement

BioMark Diagnostics (BUX) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
BioMark Diagnostics’s (BUX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting BioMark Diagnostics is a Sell.
BioMark Diagnostics’s (BUX) 20-Day exponential moving average is 0.34, while BioMark Diagnostics’s (BUX) share price is C$0.34, making it a Sell.
BioMark Diagnostics’s (BUX) 50-Day exponential moving average is 0.34, while BioMark Diagnostics’s (BUX) share price is C$0.34, making it a Sell.

BioMark Diagnostics (BUX) Pivot Points

Oct 30, 2025, 07:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.34
0.34
0.34
0.34
0.34
0.34
0.34
Fibonacci
0.34
0.34
0.34
0.34
0.34
0.34
0.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMark Diagnostics (BUX) Moving Averages

Oct 30, 2025, 07:27 PM
Period
Simple
Exponential
MA5
0.34Sell
0.34Sell
MA10
0.34Sell
0.34Sell
MA20
0.34Buy
0.34Sell
MA50
0.35Sell
0.34Sell
MA100
0.34Sell
0.33Buy
MA200
0.29Buy
0.29Buy
BioMark Diagnostics’s (BUX) 10-Day exponential moving average is 0.34, while BioMark Diagnostics’s (BUX) share price is C$0.34, making it a Sell.
BioMark Diagnostics’s (BUX) 100-Day exponential moving average is 0.33, while BioMark Diagnostics’s (BUX) share price is C$0.34, making it a Buy.
BioMark Diagnostics’s (BUX) stock price is C$0.34 and BioMark Diagnostics’s (BUX) 50-day simple moving average is 0.35, creating a Sell signal.
BioMark Diagnostics’s (BUX) stock price is C$0.34 and BioMark Diagnostics’s (BUX) 100-day simple moving average is 0.34, creating a Sell signal.
BioMark Diagnostics’s (BUX) stock price is C$0.34 and BioMark Diagnostics’s (BUX) 200-day simple moving average is 0.29, creating a Buy signal.

BioMark Diagnostics (BUX) Technical Indicators

Oct 30, 2025, 07:27 PM
Name
Value
Implied Action
RSI (14)
49.03
Neutral
STOCH (9,6)
62.50
Neutral
STOCHRSI (14)
62.96
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
37.24
Neutral
Williams %R
-44.44
Buy
CCI (14)
13.44
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
73.04
Buy
ROC
0.00
Buy
BioMark Diagnostics’s (BUX) Relative Strength Index (RSI) is 49.03, creating a Neutral signal.
BioMark Diagnostics’s (BUX) Trend Strength Indicator (ADX) is 37.24, creating a Neutral signal.
BioMark Diagnostics’s (BUX) Commodity Channel Index (CCI) is 13.44, creating a Neutral signal.

FAQ

Is BUX a Buy, Hold, or Sell?
Based on BUX’s technical indicators, BUX is a Sell.
    What is BUX’s RSI (14)?
    BUX’s RSI (14) is 49.03, which suggests BUX is a Neutral.
      What is BUX’s MACD?
      BUX’s MACD is <0.01, which suggests BUX is a Sell.
        What is BUX’s 5-day moving average?
        BUX’s 5-day moving average is 0.34, which suggests BUX is a Sell.
          What is BUX’s 20-day moving average?
          BUX 20-day moving average is 0.34, which suggests BUX is a Buy.
            What is BUX’s 50-day moving average?
            BUX’s 50-day moving average is 0.35, which suggests BUX is a Sell.
              What is BUX’s 200-day moving average?
              BUX’s 200-day moving average is 0.29, which suggests BUX is a Buy.
                What is BUX’s Williams % R (14)?
                BUX’s Williams % R (14) is -44.44, which suggests BUX is a Buy.
                  What is BUX’s CCI (14)?
                  BUX’s CCI (14) is 13.44, which suggests BUX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis